Harvard Bioscience Inc
€5.638
EUR
Last updated on --.
24h volume28.57K
24h highest5.6897 EUR
24h lowest5.0611 EUR
24h Price movement+1.24%
HBIO recent prices
24 Hours
+1.24%+€0.068976
30 days
-4.45%-€0.25435
60 days
+14.56%+€0.69407
90 days
+15.18%+€0.71994
Key data
Previous close5.5698 EUR
Market cap22.87M EUR
Volume28.57K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.8710 EUR
Net income (FY)-8.44M EUR
Revenue (FY)73.74M EUR
Last report dateMay 12, 2026
About Harvard Bioscience Inc
HeadquartersHOLLISTON
Employees (FY)339.00
Revenue per employee (FY)217.54K EUR
Net income per employee (FY)-24.88K EUR
Listed onNasdaq
HBIO conversion tables
 |  |
|---|---|
| 0.5 HBIO | 2.819 EUR |
| 1 HBIO | 5.638 EUR |
| 5 HBIO | 28.19 EUR |
| 10 HBIO | 56.38 EUR |
| |
|---|---|
| 0.5 EUR | 0.088672 HBIO |
| 1 EUR | 0.17734 HBIO |
| 5 EUR | 0.88672 HBIO |
| 10 EUR | 1.773 HBIO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
HBIO is trading at €5.638, +1.24% over the last 24 hours. Track live moves on the price chart at the top of this page.
The HBIO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HBIO is currently trading at €5.638, +1.24% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HBIO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the LABORATORY ANALYTICAL INSTRUMENTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HBIO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HBIO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HBIO's historical range and other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector.
Harvard Bioscience Inc's market cap is currently 22.87M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume28.57K
24h highest5.6897 EUR
24h lowest5.0611 EUR
24h Price movement+1.24%
Start trade with HBIO Perpetual
Sign up to trade